Perceived behavioral control emerged as a predictor of immunosuppression adherence after kidney transplantation, pointing to practical intervention targets.

Advanced CKD Increases Risk of ERCP Complications But Not PEP Alex Hillenbrand

Advanced CKD shows higher rates of certain ERCP complications but not post-ERCP pancreatitis compared with the general population.

Improved Glomerular Nephritis Diagnosis With Artificial Intelligence-Assisted Model Alex Hillenbrand

Artificial Intelligence-Assisted Model Can Automate Diagnosis of Glomerular Nephritis.

Utilizing Donor Recipient Characteristics To Improve Kidney Allograft Allocation Alex Hillenbrand

Post-transplant survival prediction algorithms can lower rates of donor discards.

High Neutrophil-To-Lymphocyte Ratio Linked to Early Renal Function Decline in IgAN Alex Hillenbrand

Elevated neutrophil-to-lymphocyte ratio predicts early kidney decline in IgA nephropathy.

ASN Kidney Week 2025 Preview: 5 Phase 3 Trials to Know Patrick Campbell

Kidney Week 2025 showcases groundbreaking clinical trials and FDA approvals, marking a transformative era in nephrology and kidney disease treatment.

Peritoneal Dialysis, Hemodialysis Yield Similar Survival Benefits for Kidney Failure Alex Hillenbrand

Meta-analysis finds peritoneal and hemodialysis offer similar survival in ESRD.

FDA Grants Orphan Drug Designation to ABBV-CLS-628 for ADPKD Alex Hillenbrand

ABBV-CLS-628, an anti–PAPP-A monoclonal antibody, earns Orphan Drug Designation, advancing through phase 2 testing for ADPKD.

5 Nephrology Headlines You Missed in October 2025 Alex Hillenbrand

October brings FDA approvals, new KDIGO guidance, and diagnostic breakthroughs

FDA Approves Kygevvi, First Treatment for Thymidine Kinase 2 Deficiency Alex Hillenbrand

The FDA has approved Kygevvi (doxycitine and doxribtimine), the first therapy to improve functional outcomes and survival in thymidine kinase 2 deficiency.

FINE-ONE: Finerenone Proves Benefit in Type 1 Diabetes and CKD Patrick Campbell

Finerenone significantly reduces UACR in type 1 diabetes patients with chronic kidney disease, offering new hope for treatment.

Kidney Week 2025: ORIGIN 3 Sets the Stage for Atacicept in IgA Nephropathy Patrick Campbell

Phase 3 trial results reveal atacicept significantly reduces proteinuria in IgA nephropathy, paving the way for potential FDA approval in 2026.

Anxiety, Depression Linked to Poor Sleep Quality in ESRD Patients on HD Alex Hillenbrand

Findings showed anxiety, depression, and sleep disorders were highly prevalent among ESRD patients undergoing maintenance hemodialysis

PISCES: Fish Oil Slashes Cardiovascular Event Risk of Maintenance Dialysis Victoria Johnson

New data on daily fish oil supplementation prompts discussions on clinical recommendations.

Almost All Adults With Hypertensive CKD Would Benefit From Lower Blood Pressure Target

DUPLEX: Sparsentan Outperforms Irbesartan in Reaching Key Proteinuria Threshold in FSGS Victoria Johnson

New findings reveal sparsentan significantly reduces proteinuria in FSGS patients, offering hope for improved kidney health and lower failure risk.

Recommended News For You

In cancer patients taking immune checkpoint inhibitors, systematic vitamin D supplementation improves outcomes.

Oncology Drug Shortages Persist, but Continue to Evolve

Life quality after childhood cancer is quantifiable thanks to outcome indicators.

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Patients face high out-of-pocket costs after incident cancer diagnosis

A Lot Can Be Said About You by Including Yourself in Photos.

10-year study shows tomosynthesis improves breast cancer detection

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News

Featured Articles

Featured Events

Featured KOL Videos

1.

Using AI, one can find cancer risk factors.

2.

Common intracellular toxin could help fight leukemia

3.

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

4.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

5.

Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition

1.

Dexamethasone and Life Expectancy After Pediatric Stem Cell Transplant

2.

Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment

3.

The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia

4.

Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies

5.

Unraveling the Mysteries of Hematocrit: How It Impacts Your Health

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

2.

Navigating the Complexities of Ph Negative ALL - Part XV

3.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

4.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

5.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Cough syrup contaminated with DEG has caused ARI and the death of many children in The Gambia.

Latest News

FDA Awards Accelerated Approval to Sibeprenlimab in IgA Nephropathy

Global Data Support Successful Pregnancy Outcomes in Kidney Transplant Recipients

Advanced CKM Stages Linked to Mortality and Liver Fibrosis in MASLD

New Evidence on Pediatric IgAN Progression Supports Need for Extended Follow-Up

Bariatric Surgery Type Impacts Survival for Older Patients with ESKD

Kidney Week 2025 Recap: 8 Trial Updates to Know in Nephrology

Todays Updates

Semaglutide Provides Cardiorenal Benefits in CKD With or Without Diabetes

Psoriasis Incidence Projected to Increase by 2025 Across Various Groups